Healthcare tech company GoodRx (NASDAQ:GDRX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on ...

Live Updates Live Coverage Updates appear automatically as they are published. Fed Leaves Rates Unchanged Amid Economic ...

The mobile advertising company disclosed that it has agreed to sell its mobile gaming business to Tripledot Studios in a deal ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES ...

The NY'C' coffee futures price for Arabica coffee remained volatile during Q1'25, peaking at US$4.25/lb in February. During ...

Industrial distributor DXP Enterprises (NASDAQ:DXPE) in Q1 CY2025, with sales up 15.5% year on year to $476.6 million. Its ...

Q1 2025 Management View CEO Mark Goldsmith highlighted significant advancements in the company's strategic priorities, particularly in the development of RAS(ON) inhibitors targeting RAS-addicted ...

The gaming technology company posted adjusted earnings per share of $0.94, missing the consensus estimate of $1.11. Revenue came in at $774 million, below analyst projections of $806.04 million.

Nutrien’s adjusted EBITDA declined 19% year-over-year to $852 million in Q1, primarily due to lower potash prices in North America and weaker retail earnings.